Cure8 research brief
The paper reports that hospitalized people with IBD have a higher risk of heparin-induced thrombocytopenia (HIT) and that HIT is associated with worse outcomes (higher mortality, longer stays, higher costs, and more clotting/bleeding).
This matters because hospitalized IBD patients routinely receive heparin for VTE prevention.
Hospitalized adults with IBD, inpatient clinicians (hospitalists, gastroenterologists), thrombosis/hematology teams, and hospital quality/safety staff.
Researchers analyzed a large national inpatient database over ten years and identified hospital stays for adults with IBD. They found that HIT was uncommon but more likely in IBD hospitalizations than in other admissions, and that IBD stays with HIT had higher odds of death, longer hospital stays, higher costs, and more clotting and bleeding complications.
What this means for patients: The findings highlight a rare but serious complication tied to heparin exposure in hospitalized people with IBD. The paper suggests balancing routine venous thromboembolism prevention with awareness and monitoring for HIT, and it calls for further study and improved HIT prevention and decision support in hospitals.
Results come from a large administrative inpatient database (National Inpatient Sample) and are based on diagnostic coding. Such studies can show associations but cannot prove causality; details about heparin exposure, timing, laboratory confirmation of HIT, and management are not available in the abstract.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
CDI occurs more often in hospitalized people with IBD than in those without IBD. Understanding which patients are at higher risk for death or complications can help hospitals prioritize early testing and management to...
People with both IBD and another immune-mediated disease (psoriatic disease) had more hospital admissions and higher inpatient costs over ten years in this population.
Active IBD was linked to higher risk of RSV infection and more severe respiratory outcomes in this large observational study. That could be relevant for prevention and monitoring during periods of active disease.
